PRESS RELEASE published on 08/06/2024 at 09:00, 1 year 8 months ago Northern Data Group announces Q2 Results, reaffirms 2024 guidance Northern Data Group reports Q2 revenue growth of 22% year-on-year to EUR 26 million, reaffirms 2024 revenue target of EUR 200-240 million, driven by Cloud and HPC infrastructure expansion Revenue Growth Northern Data Group 2024 Guidance Q2 Results HPC Solutions
PRESS RELEASE published on 08/06/2024 at 08:31, 1 year 8 months ago Cherry SE Releases 2024 Half-Year Report Cherry SE releases its 2024 Half-Year Report, showing revenue growth in DIGITAL HEALTH & SOLUTIONS segment and confirmed forecasts for 2024 Revenue Growth Cherry SE Forecasts 2024 Half-Year Report DIGITAL HEALTH & SOLUTIONS
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant son avancement vers l'objectif de recrutement complet au premier trimestre 2025 Abivax Recrutement Essai Clinique Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant l'évolution favorable du projet. La société réaffirme ses prévisions pour 2025 Abivax Recrutement Traitement Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Abivax announces ABTECT Phase 3 Trial surpasses 600-patient enrollment milestone, on track for full enrollment by early Q1 2025. Trial trends align with previous observations Abivax Obefazimod Ulcerative Colitis ABTECT Phase 3 Trial Enrollment Milestone
REGULATED PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 29/07/2024 tot 02/08/2024 Cie du Bois Sauvage voert terugkoop van eigen aandelen uit zoals gemachtigd door de buitengewone algemene vergadering van 28 april 2021 NYSE Euronext Brussel Financiële Informatie Cie Du Bois Sauvage Terugkoop Eigen Aandelen Buitengewone Algemene Vergadering
REGULATED PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage : Rachat d’actions propres – semaine du 29/07/2024 au 02/08/2024 La Compagnie du Bois Sauvage annonce le rachat de 655 actions propres sur le marché réglementé NYSE Euronext Bruxelles, conformément à l'autorisation de l'AG du 28/04/2021 Rachat D'actions NYSE Euronext Bruxelles Compagnie Du Bois Sauvage Transactions Actions Propres Autorisation AG
REGULATED PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage: Buy back of own shares – week from 29/07/2024 to 02/08/2024 Compagnie du Bois Sauvage announces buy back of own shares from 29/07/2024 to 02/08/2024, totaling €179,277.00. Details available on www.bois-sauvage.be NYSE Euronext Market Brussels Financial Transactions Own Shares Compagnie Du Bois Sauvage Buy Back
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago VALNEVA - Declaration of shares and voting rights: July 31, 2024 VALNEVA declared changes in shares and voting rights including sale, transfer, and granting of double voting rights on various dates Voting Rights Shares Sale Transfer Valneva
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago VALNEVA - Déclaration d’actions et de droits de vote : 31 juillet 2024 Déclaration d'actions et de droits de vote de Valneva pour le 31 juillet 2024. Cession et passages de titres avec droits de vote double Cession Droits De Vote Actions Valneva Double
Published on 04/29/2026 at 00:20, 1 hour 34 minutes ago Fountain Asset Corp. Announces Its Financial Results for the Quarter and Year Ended December 31, 2025
Published on 04/29/2026 at 00:00, 1 hour 54 minutes ago LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules
Published on 04/29/2026 at 00:00, 1 hour 54 minutes ago Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program
Published on 04/28/2026 at 22:15, 3 hours 39 minutes ago Preliminary figures confirmed by final financial statements 2025
Published on 04/28/2026 at 21:55, 3 hours 59 minutes ago Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
Published on 04/28/2026 at 21:00, 4 hours 54 minutes ago VAT Group AG Annual General Meeting 2026: Shareholders approved all Board proposals and a dividend increase of 12% to CHF 7.00 per share
Published on 04/28/2026 at 19:53, 6 hours ago EQS-Adhoc: Scout24 SE resolves to launch a second tranche of its share buy-back programme of up to EUR 250 million in 2026 and to shorten the buy-back period of the ongoing tranche
Published on 04/28/2026 at 19:20, 6 hours 34 minutes ago CGTN: What China's strong start to the 15th FYP period signals
Published on 04/28/2026 at 18:00, 7 hours 54 minutes ago LDC has received approval from the Competition and Markets Authority (CMA) for the acquisition of shares in Green Label
Published on 04/28/2026 at 18:00, 7 hours 54 minutes ago LDC obtient l'autorisation de la Competition and Markets Authority (CMA) pour l’opération d’achat d’actions de la Société Green Label
Published on 04/28/2026 at 17:57, 7 hours 57 minutes ago Peugeot Invest signe un accord de cession de sa participation dans Immobilière Dassault pour 75 M€
Published on 04/28/2026 at 17:57, 7 hours 57 minutes ago Peugeot Invest enters into an agreement to sell its stake in Immobilière Dassault for €75 million
Published on 04/28/2026 at 17:55, 7 hours 58 minutes ago WEB SA - ASSEMBLEE GENERALE ORDINAIRE DU 28/04/2026 - RESOLUTIONS
